Evidence map›Paper›PMID 39716608›Full record

ArticleAnnals of epidemiology2025

Misclassification of opioid-involvement in drug-related overdose deaths in the United States: A scoping review.

Sarah Gutkind, Megan E Marziali, Emilie Bruzelius, Zachary L Mannes, Silvia S Martins, Deborah S Hasin, Pia M Mauro

Abstract readScoping Review
In one paragraph

Article in Annals of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Multimodal Breathing Control: Pontomedullary Mechanisms and Current Perspectives.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah GutkindDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States. Electronic address: sg3787@cumc.columbia.edu.
Megan E MarzialiDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States. Electronic address: mem2371@cumc.columbia.edu.
Emilie BruzeliusDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States. Electronic address: eb2674@cumc.columbia.edu.
Zachary L MannesDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States; Department of Emergency Medicine, Columbia University, 530 W 166th St, New York, NY 10032, United States. Electronic address: zlm2106@cumc.columbia.edu.
Silvia S MartinsDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States. Electronic address: ssm2183@cumc.columbia.edu.
Deborah S HasinDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States; New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, United States. Electronic address: dsh2@cumc.columbia.edu.
Pia M MauroDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States. Electronic address: pm2838@cumc.columbia.edu.

Funding

Substance Abuse Epidemiology Training Program (SAETP) at Columbia UniversityT32DA031099 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEBORAH S HASIN, Silvia Saboia Martins · 2012 to 2026
$6.1M
Examining the Synergistic Effects of Cannabis and Prescription Opioid Policies on Chronic Pain, Opioid Prescribing, and Opioid OverdoseR01DA045872 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CERDA, MAGDALENA, MARTINS, SILVIA SABOIA · 2019 to 2023
$4.3M
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024R01DA048860 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2019 to 2023
$4.1M
State-level opioid policies and policies that regulate substance use duringpregnancy: a mixed methods exploration of their effects on maternal and infantoutcomesR01DA053745 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Silvia Saboia Martins, Morgan Mari Philbin · 2022 to 2026
$3.8M
Social safety net programs as interventions to reduce opioid-related harms in reproductive-age womenR01DA059376 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Silvia Saboia Martins · 2023 to 2026
$3.2M
Substance use treatment and county incarceration: Reducing inequities in substance use treatment need, availability, use, and outcomesR01DA055606 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI MAURO, PIA M. · 2023 to 2025
$2.2M
Multi-level associations between medical marijuana laws and substance use disorder treatmentK01DA045224 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAURO, PIA M. · 2018 to 2022
$878k
Barriers to and Health Consequences of Non- Pharmacological Chronic Pain Treatment among Patients Tapering Prescription Opioids in a Large Integrated Healthcare SystemK01AT012205 · NCCIH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Zachary L Mannes · 2023 to 2026
$532k
The Role of Financial Strain in Adult Alcohol, Cannabis, CNS Depressant and Polysubstance Use, and Mitigating Effects of Earned Income Tax Credit Policies: a Longitudinal Study using PATH dataR36DA058180 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GUTKIND, SARAH · 2023 to 2024
$64k
NCCIH NIH HHS K01 AT012205NIDA NIH HHS K01 DA045224NIDA NIH HHS R01 DA045872NIDA NIH HHS R01 DA048860NIDA NIH HHS R01 DA053745NIDA NIH HHS R01 DA055606NIDA NIH HHS R01 DA059376NIDA NIH HHS R36 DA058180NIDA NIH HHS T32 DA031099
6 · The paper itself

Abstract

purposeMost drug-related deaths in the United States (US) in 2022 involved opioids. However, methodological challenges in overdose surveillance may contribute to underestimation of opioid involvement in the overdose crisis. This scoping review aimed to synthesize existing literature to examine the breadth and contributing sources of misclassification of opioid-related overdose deaths.

methodsIn October 2022, we searched PubMed, Web of Science, and Scopus for studies on overdose surveillance, death certificates, and medicolegal death investigation (MDI) systems in the US published in 2013-2022. Two reviewers independently screened abstracts, reviewed full-texts, and performed data extraction of study characteristics.

resultsWe identified 17 studies examining misclassification in drug-related deaths. Across studies, opioid involvement in drug-related deaths was underestimated nationally by 20-35 %. Unspecified drug-related deaths differed by geographic areas and MDI systems and decreased over time. States/counties with coroner MDI systems were more likely to report unspecified overdose deaths than those with medical examiners. Integrating toxicology testing, death scene investigations, and other data with death certificates identified additional opioid-related overdose deaths, particularly those involving heroin.

conclusionsFindings highlight the need for additional resources for surveillance efforts, training for coroners, and data integration to improve reporting of opioid involvement in overdose deaths to inform interventions.

Indexed as

Analgesics, OpioidDrug OverdoseOpiate OverdoseOpioid-Related DisordersCause of DeathDeath CertificatesHumansUnited StatesAnalgesics, OpioidCause of deathDeath certificatesFatal drug overdoseOpioid epidemicOpioid overdose

Identifiers

PMID39716608
PMCPMC11916924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.